Arcadia Biosciences
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Arcadia Biosciences's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 46% to $5,330,000. The net income raised on -$13,981,000 and profit margin reached -262%. Total operating expenses were $15,968,000.

Profit Margin

Arcadia Biosciences, Inc. (NASDAQ:RKDA): Profit margin
2014 6.98M -18.33M -262.66%
2015 5.41M -17.95M -331.66%
2016 3.18M -19.62M -615.56%
2017 4.02M -15.70M -390.14%
2018 1.46M -13.48M -920.77%
2019 1.16M -28.87M -2469.89%
2020 8.03M -6.02M -75.01%
2021 6.78M -16.13M -237.96%
2022 9.95M -15.61M -156.81%
2023 5.33M -13.98M -262.31%

RKDA Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
5.33M9.95M6.78M8.03M1.16M1.46M4.02M3.18M5.41M6.98M
Cost of revenue
3.3M9.80M8.70M5.19M885K661K283K895K892K1.99M
Gross profit
2.03M154K-1.92M2.83M284K803K3.74M2.29M4.52M4.98M
Operating exp.
Research and development
1.38M1.50M3.88M7.96M7.09M6.06M7.40M8.66M8.96M10.01M
Selling and marketing
0000000000
Total operating expenses
15.96M19.55M26.82M24.42M20.66M17.67M18.05M20.91M20.08M20.13M
Operating income
-13.93M-19.40M-35.52M-21.59M-20.38M-16.87M-14.31M-18.62M-15.56M-15.15M
Other income (expenses), net
781K3.80M19.39M6.62M-8.49M5.95M-1.36M340K-2.36M-1.99M
Income before tax
-13.15M-15.59M-16.13M-6.15M-28.87M-13.47M-15.68M-19.59M-17.93M-17.14M
Income tax expense
8K14K2K-124K2K10K26K25K26K263K
Net income
-13.98M-15.61M-16.13M-6.02M-28.87M-13.48M-15.70M-19.62M-17.95M-18.33M
Earnings per share
Basic EPS
-11.3-26.05-30.33-24.2-181.5-143.16-291.38-353.85-503-448.39
Diluted EPS
-11.3-26.05-30.33-24.2-181.5-143.16-291.38-353.85-503-448.39
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source